Publications by authors named "Doug Bevan"

Claim this Profile
T
The Discovery of ( S)-1-(6-(3-((4-(1-(Cyclopropanecarbonyl)piperidin-4-yl)-2-methylphenyl)amino)-2,3-dihydro-1 H-inden-4-yl)pyridin-2-yl)-5-methyl-1 H-pyrazole-4-carboxylic Acid, a Soluble Guanylate Cyclase Activator Specifically Designed for Topical Ocular Delivery as a Therapy for Glaucoma.
Takeru Ehara, Christopher M Adams, Doug Bevan, Nan Ji, Erik L Meredith

J Med Chem· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design.
Jason B Cross, Jing Zhang, Qingyi Yang, Michael F Mesleh, Jan Antoinette C Romero, Doug Bevan

ACS Med Chem Lett· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis